U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H24O3
Molecular Weight 300.3921
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2-METHOXYESTRONE

SMILES

COC1=C(O)C=C2CC[C@H]3[C@@H]4CCC(=O)[C@@]4(C)CC[C@@H]3C2=C1

InChI

InChIKey=WHEUWNKSCXYKBU-QPWUGHHJSA-N
InChI=1S/C19H24O3/c1-19-8-7-12-13(15(19)5-6-18(19)21)4-3-11-9-16(20)17(22-2)10-14(11)12/h9-10,12-13,15,20H,3-8H2,1-2H3/t12-,13+,15-,19-/m0/s1

HIDE SMILES / InChI

Molecular Formula C19H24O3
Molecular Weight 300.3921
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Profiling oestrogens and testosterone in human urine by stable isotope dilution/benchtop gas chromatography-mass spectrometry.
2010-12-12
Estrogens and development of pulmonary hypertension: interaction of estradiol metabolism and pulmonary vascular disease.
2010-12
Comparison of estrogens and estrogen metabolites in human breast tissue and urine.
2010-08-02
The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo.
2010-05-21
The coordinated p53 and estrogen receptor cis-regulation at an FLT1 promoter SNP is specific to genotoxic stress and estrogenic compound.
2010-04-21
Simultaneous determination of eight estrogens and their metabolites in serum using liquid chromatography with electrochemical detection.
2010-04-15
Activity of 2 methoxyestradiol (Panzem NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: a Hoosier Oncology Group trial.
2009-10
The in vivo properties of STX243: a potent angiogenesis inhibitor in breast cancer.
2008-11-04
The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers.
2007-12-17
Evaluation of electrospray ionization and atmospheric pressure chemical ionization for simultaneous detection of estrone and its metabolites using high-performance liquid chromatography/tandem mass spectrometry.
2007-12-01
HPLC for stress-free screening of potential prostate cancer marker catechol estrogens in urine using a diamond-electrode electrochemical and a fluorescence detector.
2007-09
Effects of a catechol-O-methyltransferase inhibitor on catechol estrogen-induced cellular transformation, chromosome aberrations and apoptosis in Syrian hamster embryo cells.
2007-04-15
Estrogen metabolism modulates bone density in men.
2007-04
Urinary phytoestrogen excretion of rats bearing methylnitrosourea-induced mammary carcinoma in response to treatment with 2-methoxyestradiol.
2007-02
Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer.
2007-02
Effects of dioxin on metabolism of estrogens in waste incinerator workers.
2007-01-12
2-methoxyestradiol inhibits differentiation and is cytotoxic to osteoclasts.
2006-10-01
Plasma protein binding of the investigational anticancer agent 2-methoxyestradiol.
2006-09
The Association of the COMT V158M Polymorphism with Endometrial/Ovarian Cancer in HNPCC Families Adhering to the Amsterdam Criteria.
2006-05-15
Analysis of fifteen estrogen metabolites using packed column supercritical fluid chromatography-mass spectrometry.
2006-03-01
The role of 17beta-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer cells.
2006-01-01
A phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone-refractory prostate cancer.
2005-09-15
Selective insensitivity of ZR-75-1 human breast cancer cells to 2-methoxyestradiol: evidence for type II 17beta-hydroxysteroid dehydrogenase as the underlying cause.
2005-07-01
The oxidative metabolism of estrogen modulates response to ERT/HRT in postmenopausal women.
2004-09
Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamates.
2004-04-20
Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents.
2004-02-23
Recent translational research: antiangiogenic therapy for breast cancer - where do we stand?
2004
Comparison of ex vivo inhibitory effect between 2-hydroxyestradiol and its 17-sulfate on rat hepatic microsomal lipid peroxidation.
2003-08
The effects of 2-substituted oestrogen sulphamates on the growth of prostate and ovarian cancer cells.
2003-02
Evaluation of an EIA method for measuring serum levels of the estrogen metabolite 2-hydroxyestrone in adults.
2001-01
Involvement of genotoxic effects in the initiation of estrogen-induced cellular transformation: studies using Syrian hamster embryo cells treated with 17beta-estradiol and eight of its metabolites.
2000-04-01
Inhibition of deoxyglucose uptake in MCF-7 breast cancer cells by 2-methoxyestrone and 2-methoxyestrone-3-O-sulfamate.
2000-02-25
Altered profile of endogenous steroids in the urine of patients with prolactinoma.
1998-10
Metabolism of 2-methoxyestrone in normal men.
1983-08
Radioimmunoassay of 2-hydroxyesterone and 2-methoxyestrone in human urine.
1979-05
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:49:49 GMT 2025
Edited
by admin
on Mon Mar 31 17:49:49 GMT 2025
Record UNII
SJ5857RRL3
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GSS-33
Preferred Name English
2-METHOXYESTRONE
Common Name English
ESTRA-1,3,5(10)-TRIEN-17-ONE, 3-HYDROXY-2-METHOXY-
Systematic Name English
2-METHOXY-3-HYDROXYESTRA-1,3,5(10)-TRIEN-17-ONE
Systematic Name English
2-HYDROXYESTRONE 2-METHYL ETHER
Common Name English
2-METHOXY-17-OXOESTRA-1,3,5(10)-TRIEN-3-OL
Systematic Name English
ESTRONE, 2-METHOXY-
Common Name English
3-HYDROXY-2-METHOXYESTRA-1,3,5(10)-TRIEN-17-ONE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C2181
Created by admin on Mon Mar 31 17:49:49 GMT 2025 , Edited by admin on Mon Mar 31 17:49:49 GMT 2025
Code System Code Type Description
MESH
C003655
Created by admin on Mon Mar 31 17:49:49 GMT 2025 , Edited by admin on Mon Mar 31 17:49:49 GMT 2025
PRIMARY
WIKIPEDIA
2-Methoxyestrone
Created by admin on Mon Mar 31 17:49:49 GMT 2025 , Edited by admin on Mon Mar 31 17:49:49 GMT 2025
PRIMARY
PUBCHEM
440624
Created by admin on Mon Mar 31 17:49:49 GMT 2025 , Edited by admin on Mon Mar 31 17:49:49 GMT 2025
PRIMARY
ECHA (EC/EINECS)
206-645-6
Created by admin on Mon Mar 31 17:49:49 GMT 2025 , Edited by admin on Mon Mar 31 17:49:49 GMT 2025
PRIMARY
NCI_THESAURUS
C120472
Created by admin on Mon Mar 31 17:49:49 GMT 2025 , Edited by admin on Mon Mar 31 17:49:49 GMT 2025
PRIMARY
CHEBI
1189
Created by admin on Mon Mar 31 17:49:49 GMT 2025 , Edited by admin on Mon Mar 31 17:49:49 GMT 2025
PRIMARY
EPA CompTox
DTXSID90861900
Created by admin on Mon Mar 31 17:49:49 GMT 2025 , Edited by admin on Mon Mar 31 17:49:49 GMT 2025
PRIMARY
CAS
362-08-3
Created by admin on Mon Mar 31 17:49:49 GMT 2025 , Edited by admin on Mon Mar 31 17:49:49 GMT 2025
PRIMARY
FDA UNII
SJ5857RRL3
Created by admin on Mon Mar 31 17:49:49 GMT 2025 , Edited by admin on Mon Mar 31 17:49:49 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY